Cellebrite DI (CLBT) Other financing activities (2020 - 2025)

Cellebrite DI (CLBT) has reported Other financing activities for 6 consecutive years, with $124.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Other financing activities fell 35.06% year-over-year to $124.5 million; the TTM figure through Dec 2025 stood at $585.0 million (up 34.5% YoY), while the FY2025 annual figure was $124.5 million, down 35.06% from the prior year.
• Other financing activities came in at $124.5 million for Q4 2025 at Cellebrite DI, down from $281.4 million in the prior quarter.
• The five-year high for Other financing activities was $281.4 million in Q3 2025, with the low at -$34.0 million in Q2 2022.
• Average Other financing activities over 5 years is $107.4 million, with a median of $116.2 million recorded in 2021.
• Across the five-year window, Other financing activities surged 21086.21% in 2021 and plunged 234.22% in 2024, its largest moves.
• Year by year, Other financing activities stood at $146.0 million in 2021, then plunged by 39.96% to $87.6 million in 2022, then jumped by 116.23% to $189.5 million in 2023, then advanced by 1.13% to $191.7 million in 2024, then slumped by 35.06% to $124.5 million in 2025.
• According to Business Quant data, Other financing activities over the past three periods registered $124.5 million, $281.4 million, and $88.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.